(lp0
S"Why Infinity Pharmaceuticals Inc. Is Being Obliterated Today Motley Fool - Jun 14, 2016 So what: Infinity Pharmaceuticals released data from its phase 2 monotherapy study of duvelisib, the company's investigational compound being researched as a possible treatment for non-Hodgkin lymphoma.Infinity Pharma At Risk Of AbbVie 'Walking Away' - BenzingaInfinity Reports Topline Results From DYNAMO, A Phase 2 Monotherapy Study Of ... - PR Newswire "
p1
aS'Infinity Pharma Focuses on Cancer Drug: Competition Looms Zacks.com - Mar 21, 2017 The company also expects to complete the dose-escalation phase evaluating IPI-549 in combination with Opdivo in the second half of 2017.The Infinity Pharmaceuticals Inc.  Director Michael C. Venuti Sells 6250 ... - Petro Global News 24Michael C. Venuti Sells 6250 Shares of Infinity Pharmaceuticals Inc.  Stock - The Cerbat Gem'
p2
aS'Infinity Pharmaceuticals Inc.  Soars 5.08% on March 15 Equities.com - Mar 15, 2017 Infinity Pharmaceuticals Inc.  had a good day on the market for Wednesday March 15 as shares jumped 5.08% to close at $3.10.Infinity Pharmaceuticals Inc.  Forecasted to Post FY2019 Earnings of ($0 ... - Chaffey BreezeInfinity Pharmaceuticals Inc.  Updates Phase I Trial Report - StockNewsUnion'
p3
aS'Infinity Announces Organizational Changes PR Newswire  - Jan 4, 2017 CAMBRIDGE, Mass., Jan. 4, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  today announced that Lawrence Bloch, M.D.Infinity Pharma R&amp;D Chief Adams Retires Amid Restructuring, Job Cuts - Xconomy'
p4
aS'Infinity Pharmaceuticals Inc  Pushes Higher 7.12% Business Review - 11 hours ago Pushing higher over the last five sessions are shares of Infinity Pharmaceuticals Inc . The stock has risen 7.12% over that span, yielding profits for savvy traders.'
p5
aS'Infinity Pharma Surges On Latest Cancer Drug Hope Seeking Alpha - Jan 25, 2017 Infinity Pharma  has seen its stock price shoot up in recent days due to promising preclinical data on its IPI-549 cancer drug.'
p6
aS'Infinity Pharmaceuticals  Catches Eye: Stock Up 13.5% Yahoo Finance - Mar 1, 2017 Infinity Pharmaceuticals, Inc. INFI was a big mover last session, as the company saw its shares rise almost 7% on the day.Infinity Pharmaceuticals Inc.  Plunges 5.65% on March 03 - Equities.comWhy did Infinity Pharmaceuticals, Inc.  Gain +20%? - StockNewsUnion'
p7
aS"Infinity Presents Preclinical Data and Phase 1 Clinical Data on IPI-549 at ... PR Newswire  - Jan 20, 2017 CAMBRIDGE, Mass., Jan. 20, 2017 /PRNewswire/ -- Today, during a plenary session at the Keystone Symposia Conference, &quot;PI3K Pathways in Immunology, Growth Disorders and Cancer,&quot; Infinity Pharmaceuticals, Inc.  presented preclinical&nbsp;...Infinity Pharma's lead product candidate IPI-549 shows encouraging results in ... - Seeking Alpha"
p8
aS'Infinity to Present at 37th Annual Cowen and Company Healthcare Conference PR Newswire  - Feb 27, 2017 CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  will be presenting at the Cowen and Company 37th Annual Healthcare Conference on Monday, March 6, 2017, at 4:00 p.m. ET in Boston, MA. A live webcast of&nbsp;...'
p9
aS'Infinity Announces Promotion of Jeffery Kutok, MD, Ph.D. to Chief Scientific ... PR Newswire  - Feb 13, 2017 CAMBRIDGE, Mass., Feb. 13, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  today announced that Jeffery Kutok, M.D.Infinity Pharmaceuticals  Stock: Up Big On Management Announcement - CNA Finance '
p10
a.